CN1553795A - 抗皮肤老化的药物和化妆品组合物 - Google Patents
抗皮肤老化的药物和化妆品组合物 Download PDFInfo
- Publication number
- CN1553795A CN1553795A CNA028098919A CN02809891A CN1553795A CN 1553795 A CN1553795 A CN 1553795A CN A028098919 A CNA028098919 A CN A028098919A CN 02809891 A CN02809891 A CN 02809891A CN 1553795 A CN1553795 A CN 1553795A
- Authority
- CN
- China
- Prior art keywords
- phosphatide complexes
- standard
- extract
- cosmetic composition
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 239000002537 cosmetic Substances 0.000 title claims abstract description 14
- 230000009759 skin aging Effects 0.000 title abstract description 4
- 239000000284 extract Substances 0.000 claims abstract description 27
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- 235000009392 Vitis Nutrition 0.000 claims description 12
- 241000219095 Vitis Species 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 11
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 10
- 241000196324 Embryophyta Species 0.000 claims description 5
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- 229960003720 enoxolone Drugs 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 150000001261 hydroxy acids Chemical class 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 244000146462 Centella asiatica Species 0.000 abstract description 2
- 235000004032 Centella asiatica Nutrition 0.000 abstract description 2
- 235000014787 Vitis vinifera Nutrition 0.000 abstract description 2
- 240000006365 Vitis vinifera Species 0.000 abstract description 2
- 235000002532 grape seed extract Nutrition 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 11
- 230000032683 aging Effects 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- -1 triterpenoid compound Chemical class 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 5
- 239000004365 Protease Substances 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 206010051246 Photodermatosis Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 230000008845 photoaging Effects 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 2
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 241001440269 Cutina Species 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 229940074979 cetyl palmitate Drugs 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 2
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 2
- 229940060384 isostearyl isostearate Drugs 0.000 description 2
- 229940031674 laureth-7 Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 2
- 229940011656 madecassic acid Drugs 0.000 description 2
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- JPMIIZHYYWMHDT-UHFFFAOYSA-N octhilinone Chemical compound CCCCCCCCN1SC=CC1=O JPMIIZHYYWMHDT-UHFFFAOYSA-N 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920001195 polyisoprene Polymers 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical group O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-M nonanoate Chemical compound CCCCCCCCC([O-])=O FBUKVWPVBMHYJY-UHFFFAOYSA-M 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Abstract
用于防止皮肤老化的药物和化妆品组合物，其含有葡萄提取物的磷脂复合物以及标准积雪草提取物的磷脂复合物。
Description
本发明涉及含有植物来源成分的对抗皮肤老化的药物和化妆品组合物。
更具体地讲，本发明涉及用于预防皮肤老化的药物和化妆品组合物，其含有葡萄(Vitis vinifera)提取物的磷脂复合物以及自积雪草(Centellaasiatica)提取的三萜类化合物的磷脂复合物。
皮肤老化是一个可影响各个皮肤层的复杂的生物过程，但是它的主要影响见于真皮层。存在两种生物学上独立的、同时发生的老化过程。第一种是内源性老化，可影响皮肤以及很可能影响内脏器官。第二种是外源性老化或光老化，是暴露于环境、主要是紫外线照射的结果。内源性老化的后果可见于全身皮肤，包括不受阳光照射的部位。在暴露于阳光的部位、特别是在面部和手背，光老化损害和内源性老化所致的组织退化共同发挥作用。因此，患者所关心的主要部位，即面部和颈部皮肤的最明显的变化是内源性和外源性老化过程共同作用的结果。尽管其它因素(例如吸烟)可能导致皱纹过早产生，但达80％的面部老化已显示可归因于暴露于阳光。
从生物化学的观点而言，光老化被认为主要是由角质形成细胞和成纤维细胞与紫外照射相互作用而过量产生和过量释放的一些蛋白酶，主要是金属蛋白酶(这些蛋白酶是不可逆地损伤胶原蛋白、弹性蛋白和透明质酸的降解酶，致使在真皮留下疤痕及可见的皱纹)，以及能够在很短的时间内消除正常皮肤抗氧化防御体系的氧化压力。
基于这些常见原因，显然需要通过一种能够抵消蛋白酶对真皮的作用(并可增加成纤维细胞产生和释放新的胶原蛋白纤维的能力)并阻止皮肤抗氧化防御体系的消失的手段，以避免皮肤的过早老化。
本发明通过提供含有以下植物来源的成分的药物和化妆品组合物而满足了这种需求：
a)标准葡萄提取物的磷脂复合物 0.1至2.5％
b)标准积雪草提取物的磷脂复合物 0.1至2.5％
更优选地，本发明的药物和化妆品组合物含有以下植物来源的成分，并具有以下百分比：
a)标准葡萄提取物的磷脂复合物 1％
b)标准积雪草提取物的磷脂复合物 1％
EP275,224公开了标准葡萄提取物的磷脂复合物(也被称为“组分a”)。所述提取物由包含在葡萄籽中的多酚类部分组成，并包含没食子酸、游离的和与没食子酸酯化的儿茶素及表儿茶素的单体、二聚物、三聚物、四聚物、五聚物、六聚物和七聚物。
体外及体内研究已证实：所述提取物具有高度的抗氧化活性(基于实验模型的不同为维生素E的抗氧化活性的10至200倍)，其包括清除最具反应活性的基团类别，并对抗所有与自由基的作用有关的现象。所述提取物的特征还在于能够抑制黄嘌呤氧化酶并与Cu++及Fe+++螯合，从而阻止组织中酶催化的自由基的释放。最后，葡萄提取物可抑制胶原酶和其它蛋白酶，从而使结缔组织和皮肤免受紫外线照射后和炎性皮肤反应的进展期间所释放的蛋白水解酶的损害作用，并且它对皮肤和循环组织如微血管和毛细血管具有选择性的亲和力，从而也可对微循环区起到保护作用。
EP283,713公开了标准积雪草提取物的磷脂复合物(也被称为“组分b”)。
该提取物由对胶原蛋白代谢具有强大作用的三种不同分子的4∶3∶3混合物组成，所述分子为积雪草甙、积雪草酸和羟基积雪草酸(madecassicacid)。这些分子可提高成纤维细胞摄取氨基酸如L-脯氨酸和L-羟脯氨酸(从定性-定量观点而言是胶原蛋白组成中最重要的氨基酸)的能力。胶原蛋白的合成增加意味着退化的旧胶原蛋白纤维可更快地被新的胶原蛋白纤维所代替。
当进行毒理学试验时，组分a)和b)表现出对被治疗组织既无毒性亦无刺激作用。
除以上所指出的组分a)和b)外，本发明的组合物还可以任选地包含其它活性成分如维生素E(0.2至1％)、锌(0.1至0.3％)、羟基酸(0.1至1％)及甘草亭酸或其与磷脂的复合物(0.1至2.5％)，以提高组合物的抗氧化、抗老化和抗炎性质。
本发明的组合物可以以适宜的液体制剂(如凝胶、洗液、乳液(milks)、乳剂、泡沫剂等)或固体或半固体制剂(如乳膏、软膏、唇膏等)的形式局部施用。根据常规的方法如那些在“Remington’s PharmaceuticalHandbook”(Mack出版公司，纽约，美国)中述及的方法，连同适宜的赋形剂如润滑剂、保湿剂、增稠剂、乳化剂、染料、矫味剂等，可制备所述制剂。
以下报告了发明的组合物的某些实施例。
实施例1-水包油乳剂
100克乳剂含有：
葡萄提取物的磷脂复合物 0.20克
自积雪草提取的三萜类化合物的磷脂复合物 1.00克
异硬脂酸异硬脂醇酯(Gattefosse) 2.50克
聚异戊二烯(Syntesqual-Vevy) 2.50克
油酸癸酯(Cetiol V-Henkel) 2.00克
鲸蜡醇十六酸酯(Cutina CP-Henkel) 2.00克
十六硬脂醇异壬酸酯
(cetearyl isononanoate，Cetiol SN-Henkel) 2.00克
聚山梨酸酯80(吐温80-ICI) 1.00克
咪唑烷基脲 0.30克
生育酚 0.20克
棕榈酸抗坏血酸酯 0.10克
甲基氯异噻唑啉酮(e)甲基异噻唑啉酮
(Kathon CG-Rohm & Haas) 0.05克
EDTA二钠 0.10克
丁化羟基甲苯 0.05克
聚丙烯酰胺(e)C13-14异链烷烃(e)
Laureth-7(Spiegel 305-Seppic) 2.50克
香料 0.10克
纯水 加至100.0克
实施例2-水包油乳剂
100克乳剂含有：
葡萄提取物的磷脂复合物 0.50克
自积雪草提取的三萜类化合物的磷脂复合物 0.50克
甘草亭酸的磷脂复合物 1.50克
C12-15烷基苯甲酸酯(Finsolv TN-Finetex) 4.00克
鲸蜡醇十六酸酯(Cutina CP-Henkel) 3.00克
聚异戊二烯(Syntesqual-Vevy) 2.50克
异硬脂酸异硬脂醇酯(Gattefosse) 2.50克
聚山梨酸酯80(吐温80-ICI) 1.00克
咪唑烷基脲 0.30克
甲基氯异噻唑啉酮(e)甲基异噻唑啉酮
(Kathon CG-Rohm & Haas) 0.05克
生育酚 0.20克
棕榈酸抗坏血酸酯 0.10克
EDTA二钠 0.10克
柠檬酸 0.05克
聚丙烯酰胺(e)C13-14异链烷烃(e)
Laureth-7(Spiegel 305-Seppic) 2.00克
丁化羟基甲苯 0.05克
香料 0.10克
纯水 加至100.0克
Claims (7)
1.含有以下植物来源的成分：
a)标准葡萄提取物的磷脂复合物 0.1至2.5％
b)标准积雪草提取物的磷脂复合物 0.1至2.5％以及常规赋形剂和载体的药物和化妆品组合物。
2.权利要求1所述的药物和化妆品组合物，其含有以下植物来源的成分：
a)标准葡萄提取物的磷脂复合物 1％
b)标准积雪草提取物的磷脂复合物 1％以及常规赋形剂和载体。
3.权利要求1和2所述的药物和化妆品组合物，其还含有其它选自维生素E、锌、羟基酸和甘草亭酸或其与磷脂的复合物的活性成分。
4.权利要求3所述的药物和化妆品组合物，其中其它活性成分的百分含量为：
维生素E 0.2至1％
锌 0.1至0.3％
羟基酸 0.1至1％
甘草亭酸或其与磷脂的复合物 0.1至2.5％
5.a)标准葡萄提取物的磷脂复合物，和
b)标准积雪草提取物的磷脂复合物在制备抗皮肤老化的药物和化妆品组合物中的用途。
6.a)标准葡萄提取物的磷脂复合物，和
b)标准积雪草提取物的磷脂复合物与其它选自维生素E、锌、羟基酸和甘草亭酸或其与磷脂的复合物的活性成分的组合在制备抗皮肤老化的药物和化妆品组合物中的用途。
7.上述任何一项权利要求所述的化妆品组合物用于抗皮肤老化的用途。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI001022A ITMI20011022A1 (it) | 2001-05-17 | 2001-05-17 | Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo |
| ITMI2001A001022 | 2001-05-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1553795A true CN1553795A (zh) | 2004-12-08 |
| CN100387219C CN100387219C (zh) | 2008-05-14 |
Family
ID=11447682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB028098919A Expired - Fee Related CN100387219C (zh) | 2001-05-17 | 2002-05-10 | 抗皮肤老化的药物和化妆品组合物 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7214395B2 (zh) |
| EP (1) | EP1390008B1 (zh) |
| JP (1) | JP2004529951A (zh) |
| KR (1) | KR100891219B1 (zh) |
| CN (1) | CN100387219C (zh) |
| AT (1) | ATE400248T1 (zh) |
| AU (1) | AU2002342279B2 (zh) |
| CA (1) | CA2447525C (zh) |
| CZ (1) | CZ299709B6 (zh) |
| DE (1) | DE60227505D1 (zh) |
| DK (1) | DK1390008T3 (zh) |
| ES (1) | ES2309182T3 (zh) |
| HK (1) | HK1069102A1 (zh) |
| HU (1) | HU230037B1 (zh) |
| IL (2) | IL158878A0 (zh) |
| IT (1) | ITMI20011022A1 (zh) |
| NO (1) | NO334186B1 (zh) |
| PL (1) | PL204127B1 (zh) |
| PT (1) | PT1390008E (zh) |
| RU (1) | RU2290921C2 (zh) |
| SI (1) | SI1390008T1 (zh) |
| SK (1) | SK287064B6 (zh) |
| WO (1) | WO2002092042A2 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105662974A (zh) * | 2016-03-10 | 2016-06-15 | 江苏隆力奇生物科技股份有限公司 | 一种预防皮肤光老化功能制剂及其应用 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20031789A1 (it) * | 2003-09-19 | 2005-03-20 | Indena Spa | Composizioni farmaceutiche e cosmetiche per il trattamento |
| JP2005247826A (ja) * | 2004-02-04 | 2005-09-15 | Kose Corp | デコリン産生促進剤及びそれを含有する皮膚外用剤 |
| DK2233127T3 (da) | 2004-03-17 | 2020-08-24 | Stada Arzneimittel Ag | Anvendelse af antioxidanter til fremstilling af en farmaceutisk eller kosmetisk sammensætning for at beskytte huden mod skader som følge af infrarød stråling |
| WO2006052037A1 (en) * | 2004-11-10 | 2006-05-18 | Lg Household & Health Care Ltd. | Base composition for anti-wrinkle of lips, lipstick containing the same and manufacturing method thereof |
| JP2008255020A (ja) * | 2007-04-02 | 2008-10-23 | Fujifilm Corp | 抗老化皮膚外用剤 |
| WO2008142619A1 (en) * | 2007-05-17 | 2008-11-27 | Izun Pharmaceuticals Corporation | Use of herbal compositions in the protection and enhancement of extracellular matrix components |
| FR2919182B1 (fr) * | 2007-07-25 | 2009-11-13 | Trophos | Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants |
| EP2229165A1 (en) * | 2007-12-06 | 2010-09-22 | Bayer Consumer Care AG | Anti-glycation properties of asicatic acid and madecassic acid |
| DE102008014289A1 (de) | 2008-03-11 | 2009-09-17 | Coty Prestige Lancaster Group Gmbh | Kosmetikum mit Anti-Alterungswirkung |
| FR2934160B1 (fr) | 2008-07-25 | 2012-12-07 | Lvmh Rech | Procede de preparation d'un extrait lipophile de vigne. |
| US7855826B2 (en) * | 2008-08-12 | 2010-12-21 | Qualcomm Mems Technologies, Inc. | Method and apparatus to reduce or eliminate stiction and image retention in interferometric modulator devices |
| JP5746864B2 (ja) | 2008-11-19 | 2015-07-08 | ポーラ化成工業株式会社 | シワ改善剤 |
| CA2858211C (en) | 2011-12-09 | 2018-08-21 | Mary Kay Inc. | Skin care formulation |
| ES2702398A1 (es) * | 2017-08-30 | 2019-02-28 | Lacer Sa | Composiciones para la cicatrización de heridas |
| WO2021184125A1 (en) * | 2020-03-19 | 2021-09-23 | Idunn Technologies | Discovery of fifteen new anti-aging plant extracts and identification of cellular processes they affect as new caloric restriction mimetics |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4693527A (en) * | 1986-04-28 | 1987-09-15 | Litton Systems, Inc. | Rolling loop twist capsule |
| IT1201151B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono |
| US5166139A (en) * | 1987-02-26 | 1992-11-24 | Indena, S.P.A. | Complexes of saponins and their aglycons with phospholipids and pharmaceutical and cosmetic compositions containing them |
| IT1203515B (it) * | 1987-02-26 | 1989-02-15 | Indena Spa | Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono |
| US5554647A (en) * | 1989-10-12 | 1996-09-10 | Perricone; Nicholas V. | Method and compositions for treatment and/or prevention of skin damage and aging |
| FR2714382B1 (fr) | 1993-12-27 | 1996-02-02 | Roussel Uclaf | Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques. |
| FR2787996B1 (fr) | 1998-12-30 | 2002-05-10 | Dior Christian Parfums | Composition cosmetique ou dermatologique contenant un actif stimulant la synthese de la proteine hsp 32 dans la peau et methode de traitement cosmetique |
| EP1276457B1 (en) * | 2000-04-18 | 2011-12-14 | Medestea Internazionale S.p.A. | A composition based on natural extracts useful in the prevention and treatment of cutaneous wrinkles |
-
2001
- 2001-05-17 IT IT2001MI001022A patent/ITMI20011022A1/it unknown
-
2002
- 2002-05-10 ES ES02742981T patent/ES2309182T3/es not_active Expired - Lifetime
- 2002-05-10 CZ CZ20033111A patent/CZ299709B6/cs not_active IP Right Cessation
- 2002-05-10 DK DK02742981T patent/DK1390008T3/da active
- 2002-05-10 SK SK1417-2003A patent/SK287064B6/sk not_active IP Right Cessation
- 2002-05-10 IL IL15887802A patent/IL158878A0/xx unknown
- 2002-05-10 WO PCT/EP2002/005147 patent/WO2002092042A2/en active IP Right Grant
- 2002-05-10 JP JP2002588961A patent/JP2004529951A/ja active Pending
- 2002-05-10 CA CA2447525A patent/CA2447525C/en not_active Expired - Lifetime
- 2002-05-10 AU AU2002342279A patent/AU2002342279B2/en not_active Ceased
- 2002-05-10 EP EP02742981A patent/EP1390008B1/en not_active Expired - Lifetime
- 2002-05-10 CN CNB028098919A patent/CN100387219C/zh not_active Expired - Fee Related
- 2002-05-10 HU HU0304077A patent/HU230037B1/hu not_active IP Right Cessation
- 2002-05-10 KR KR1020037014721A patent/KR100891219B1/ko active IP Right Grant
- 2002-05-10 DE DE60227505T patent/DE60227505D1/de not_active Expired - Lifetime
- 2002-05-10 SI SI200230706T patent/SI1390008T1/sl unknown
- 2002-05-10 US US10/477,703 patent/US7214395B2/en not_active Expired - Lifetime
- 2002-05-10 RU RU2003133289/15A patent/RU2290921C2/ru active
- 2002-05-10 AT AT02742981T patent/ATE400248T1/de active
- 2002-05-10 PT PT02742981T patent/PT1390008E/pt unknown
- 2002-05-10 PL PL366605A patent/PL204127B1/pl unknown
-
2003
- 2003-11-13 IL IL158878A patent/IL158878A/en active IP Right Grant
- 2003-11-14 NO NO20035076A patent/NO334186B1/no not_active IP Right Cessation
-
2005
- 2005-01-10 HK HK05100182A patent/HK1069102A1/xx not_active IP Right Cessation
-
2007
- 2007-04-09 US US11/783,331 patent/US7354610B2/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105662974A (zh) * | 2016-03-10 | 2016-06-15 | 江苏隆力奇生物科技股份有限公司 | 一种预防皮肤光老化功能制剂及其应用 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7354610B2 (en) | Pharmaceutical and cosmetic composition against skin aging | |
| US5254331A (en) | Skin cream composition | |
| JP4313846B2 (ja) | ビタミンｃ若しくはその誘導体又はそれらの類似体の，皮膚エラスチン合成促進のための使用 | |
| CN108096071A (zh) | 一种可修复受损肌肤的精华油及其制备方法 | |
| CN1198927A (zh) | 含有西印度草莓樱桃发酵物的皮肤增白剂组合物 | |
| US20040013618A1 (en) | Cosmetic formulation | |
| CN111297745A (zh) | 一种促进吸收的美白组合物及其生产工艺和应用 | |
| AU2002342279A1 (en) | Pharmaceutical and cosmetic compositions against skin aging | |
| JPH06504282A (ja) | 化粧用又は薬用製剤 | |
| US8383594B2 (en) | Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals | |
| CN1607932A (zh) | 改善皮肤美学外观的方法 | |
| WO2007000651A1 (en) | Pharmaceutical and cosmetic compositions containing colostrum, tocopherols, zinc oxide and hyaluronic acid | |
| US5776438A (en) | External preparation | |
| FR2853539A1 (fr) | COMPOSITION COSMETIQUE COMPRENANT LE FROPs ET LE RROPS, ET SON UTILISATION EN COSMETIQUE POUR UNE ACTION ANTI-VIEILLISSEMENT CUTANEE | |
| CN108354887A (zh) | 一种含有鱼籽提取液和弹性蛋白的护肤水及其制备方法 | |
| KR102558825B1 (ko) | 엘카르니틴 및 항염증 펩타이드를 유효성분으로 포함하는 윤곽주사 조성물 | |
| KR20060101456A (ko) | 셀룰라이트의 치료를 위한 경구용 조성물 | |
| JP3512890B2 (ja) | 皮膚老化防止用外用剤 | |
| Larkina et al. | EFFECT OF CALCIUM HYDROXYAPATITE AND HYALURONIC ACID INJECTIONS ON INFLAMMATION MARKERS OF PERIODONT TISSUE | |
| WO2023141799A1 (en) | A composition against osmotic stress | |
| WO2023156071A1 (en) | Kit of cosmetic compositions | |
| CN115364017A (zh) | 一种胶原活性肽护肤组合物及其制备方法 | |
| CN113453675A (zh) | 辛酸和癸酸甘油三酯用于治疗由丝聚蛋白或胶原蛋白缺乏介导的疾病或病症的用途 | |
| RO120382B1 (ro) | Cremă de noapte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1069102 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1069102 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080514 Termination date: 20210510 |